Literature DB >> 11904338

Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas.

Ana-Isabel Sáez1, María-Jesús Artiga, Margarita Sánchez-Beato, Lydia Sánchez-Verde, Juan-Fernando García, Francisca-Inmaculada Camacho, Renato Franco, Miguel A Piris.   

Abstract

Oct1 and Oct2 are transcription factors of the POU homeo-domain family that bind to the Ig gene octamer sites, regulating B-cell-specific genes. The function of these transcription factors is dependent on the activity of B-cell-restricted coactivators such as BOB.1/OBF.1. Independent studies of the expression of these proteins in non-Hodgkin's lymphoma have been restricted to single markers, and most lack data concerning immunohistochemical expression. Thus, we have investigated the expression of Oct1, Oct2, and BOB.1/OBF.1 in human reactive lymphoid tissue and in a series of 140 Hodgkin and non-Hodgkin's lymphomas. None of these proteins was found to be restricted to B cells, although only B cells expressed high levels of all three markers. Additionally, germinal center B cells showed stronger Oct2 and BOB.1/OBF.1 staining. Consequently, most B-cell lymphomas showed reactivity for all three antibodies. Oct2 expression was significantly higher in germinal center-derived lymphomas, although other B-cell lymphomas also displayed a high level of Oct2 expression. Although T-cell lymphomas and Hodgkin's lymphomas expressed some of these proteins, they commonly exhibited less reactivity than B-cell lymphomas. Despite not being entirely cell-specific, the strong nuclear expression of Oct2 and BOB.1/OBF.1 by germinal center- derived lymphomas makes these antibodies a potentially useful tool in lymphoma diagnosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11904338     DOI: 10.1038/modpathol.3880518

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  14 in total

1.  Loss of expression of the WNT/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas.

Authors:  David M Dorfman; Harvey A Greisman; Aliakbar Shahsafaei
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

2.  Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas.

Authors:  Cigdem Atayar; Sibrand Poppema; Tjasso Blokzijl; Geert Harms; Marcel Boot; Anke van den Berg
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

3.  Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms.

Authors:  Teresa Marafioti; Stefano Ascani; Karen Pulford; Elena Sabattini; Milena Piccioli; Margaret Jones; Pier Luigi Zinzani; Georges Delsol; David Y Mason; Stefano A Pileri
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

4.  OCT2 pre-positioning facilitates cell fate transition and chromatin architecture changes in humoral immunity.

Authors:  Ashley S Doane; Chi-Shuen Chu; Dafne Campigli Di Giammartino; Martín A Rivas; Johannes C Hellmuth; Yanwen Jiang; Nevin Yusufova; Alicia Alonso; Robert G Roeder; Effie Apostolou; Ari M Melnick; Olivier Elemento
Journal:  Nat Immunol       Date:  2021-09-23       Impact factor: 25.606

5.  Pathophysiology and molecular aspects of diffuse large B-cell lymphoma.

Authors:  Gisele Rodrigues Gouveia; Sheila Aparecida Coelho Siqueira; Juliana Pereira
Journal:  Rev Bras Hematol Hemoter       Date:  2012

6.  Aberrant expression of multiple T cell markers on diffuse large B cell lymphoma: a case report.

Authors:  Anurag Mehta; Prerna Chadha; Poojan Agarwal; Sunil Pasricha
Journal:  J Egypt Natl Canc Inst       Date:  2021-06-15

7.  CluGene: A Bioinformatics Framework for the Identification of Co-Localized, Co-Expressed and Co-Regulated Genes Aimed at the Investigation of Transcriptional Regulatory Networks from High-Throughput Expression Data.

Authors:  Tania Dottorini; Pietro Palladino; Nicola Senin; Tania Persampieri; Roberta Spaccapelo; Andrea Crisanti
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

8.  Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand.

Authors:  Tawatchai Pongpruttipan; Tanawan Kummalue; Anan Bedavanija; Archrob Khuhapinant; Koichi Ohshima; Fumiko Arakawa; Daisuke Niino; Sanya Sukpanichnant
Journal:  Diagn Pathol       Date:  2011-08-25       Impact factor: 2.644

9.  Bob1 limits cellular frequency of T-follicular helper cells.

Authors:  Keiji Yamashita; Koji Kawata; Hiroshi Matsumiya; Ryuta Kamekura; Sumito Jitsukawa; Tomonori Nagaya; Noriko Ogasawara; Ken-Ichi Takano; Terufumi Kubo; Sachiko Kimura; Katsunori Shigehara; Tetsuo Himi; Shingo Ichimiya
Journal:  Eur J Immunol       Date:  2016-05-03       Impact factor: 5.532

10.  Automatic identification of informative regions with epigenomic changes associated to hematopoiesis.

Authors:  Enrique Carrillo-de-Santa-Pau; David Juan; Vera Pancaldi; Felipe Were; Ignacio Martin-Subero; Daniel Rico; Alfonso Valencia
Journal:  Nucleic Acids Res       Date:  2017-09-19       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.